🇺🇸 Daily DPP-4 inhibitor in United States

Daily DPP-4 inhibitor (Daily DPP-4 inhibitor) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Daily DPP-4 inhibitor in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Daily DPP-4 inhibitor approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Daily DPP-4 inhibitor in United States?

Haisco Pharmaceutical Group Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.